Dóra Balogh
Semmelweis University(HU)
Publications by Year
Research Areas
Pharmacological Receptor Mechanisms and Effects, Diabetes Treatment and Management, Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Pancreatic function and diabetes
Most-Cited Works
- → RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition(2018)92 cited
- → σ1-Receptor Agonism Protects against Renal Ischemia-Reperfusion Injury(2016)59 cited
- → Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney(2020)51 cited
- → Role ofO-linkedN-acetylglucosamine modification in diabetic nephropathy(2016)51 cited
- → SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes(2022)35 cited
- → An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis(2023)31 cited
- → The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats(2016)28 cited
- → Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling(2019)24 cited
- → The role of Sigma-1 receptor in sex-specific heat shock response in an experimental rat model of renal ischaemia/reperfusion injury(2018)23 cited
- → Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition(2020)19 cited